Sphera Funds Management’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,110	Closed	-$3.88M	–	100
2019 Q1	$3.88M	Buy	3,110 +600	+24%	+$687K	0.53%	68
2018 Q4	$2.38M	Hold	2,510	–	–	0.34%	68
2018 Q3	$3.62M	Buy	2,510 +111	+5%	+$168K	0.47%	73
2018 Q2	$3.87M	Buy	2,399 +899	+60%	+$1.55M	0.61%	56
2018 Q1	$2.44M	Sell	1,500 -1,750	-54%	-$3.64M	0.42%	72
2017 Q4	$5.46M	Buy	+3,250	New	+$4.3M	0.87%	34
2017 Q3	–	Sell	-3,208	Closed	-$3.58M	–	139
2017 Q2	$3.58M	Sell	3,208 -4,550	-59%	-$3.76M	0.73%	51
2017 Q1	$4.21M	Buy	7,758 +300	+4%	+$184K	1.08%	30
2016 Q4	$4.55M	Buy	7,458 +277	+4%	+$173K	1.4%	23
2016 Q3	$5.13M	Hold	7,181	–	–	1.18%	27
2016 Q2	$5.22M	Buy	7,181 +3,802	+113%	+$2.62M	1.46%	16
2016 Q1	$2.01M	Buy	+3,379	New	+$1.73M	0.54%	48
2014 Q2	–	Sell	-1,060	Closed	-$1.73M	–	110
2014 Q1	$1.73M	Buy	+1,060	New	+$1.28M	0.41%	55